Clover Health Investments (CLOV) Reports Q2 results; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mail
Get Alerts CLOV Hot Sheet
Join SI Premium – FREE
Clover Health Investments (NASDAQ: CLOV) reported Q2 Revenue for the quarter at $477.62 million versus the consensus estimate of $468.3 million.
GUIDANCE:
Clover Health Investments sees FY2025 revenue of $1.8-1.875 billion, versus the consensus of $1.863 billion.
For earnings history and earnings-related data on Clover Health Investments (CLOV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aptiv (APTV) Tops Q3 EPS by 9c; offers guidance
- Dynatrace Inc. (DT) Tops Q2 EPS by 5c ; Offers Guidance
- Pfizer (PFE) Tops Q3 EPS by 14c, Beats on Revenue; Offers FY26 Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
